Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells
Abstract:Sphingosine 1-phosphate (S1P), a metabolite of sphingomyelin degradation, stimulates interleukin-8 (IL-8) secretion in human bronchial epithelial (Beas-2B) cells. The molecular mechanisms regulating S1P-mediated IL-8 secretion are yet to be completely defined. Here we provide evidence that activation of phospholipases D1 and D2 (PLD1 and PLD2) by S1P regulates the phosphorylation of extracellular-signal-regulated kinase (ERK) and IL-8 secretion in Beas-2B cells. S1P, in a time- and dose-dependent manner, enhan… Show more
“…BEAS-2B cells maintain the characteristics of primary bronchial epithelial cells including expression of ICAM-1, eotaxin and CXCL8 [19][20][21], while KU812 cells constitute the phenotypes of basophils, such as histamine release and FcgammaRII expression [22]. We also used primary bronchial epithelial cells and peripheral blood basophils to confirm our findings of BEAS-2B and KU812 cells.…”
Basophils are the accessory cell type for T-helper (Th)2 induction and initiators in immunoglobulin E-mediated chronic allergic inflammation. Basophils and Th17 cells accumulate at the inflammatory sites, such as the airways of allergic asthmatic patients.We investigated the activation of interleukin (IL)-17A on the primary human basophils/KU812 basophilic cells and primary human bronchial epithelial cells/BEAS-2B bronchial epithelial cells. Cytokines, chemokines, adhesion molecules and intracellular signalling molecules were assayed by ELISA or flow cytometry.Co-culture of bronchial epithelial cells and basophils could significantly induce the release of IL-6, an epithelial inflammatory cytokine, and CCL2, a chemokine for basophils, esosinophils and monocytes. Such induction was synergistically enhanced by IL-17A, and direct interaction between these two cells was necessary for IL-17A-induced IL-6 and CCL2 release. Surface expression of intercellular adhesion molecule-1 on bronchial epithelial cells was also upregulated upon their interaction. The interaction of basophils and bronchial epithelial cells under IL-17A stimulation was differentially regulated by extracellular signal-regulated kinase, c-Jun N-terminal protein kinase, p38 mitogen-activated protein kinase and nuclear factor-kB pathways.These findings suggest a novel immunopathological role of Th17 cells and basophils in allergic asthma through the activation of granulocyte-mediated inflammation initiated by the direct interaction between basophils and bronchial epithelial cells.
“…BEAS-2B cells maintain the characteristics of primary bronchial epithelial cells including expression of ICAM-1, eotaxin and CXCL8 [19][20][21], while KU812 cells constitute the phenotypes of basophils, such as histamine release and FcgammaRII expression [22]. We also used primary bronchial epithelial cells and peripheral blood basophils to confirm our findings of BEAS-2B and KU812 cells.…”
Basophils are the accessory cell type for T-helper (Th)2 induction and initiators in immunoglobulin E-mediated chronic allergic inflammation. Basophils and Th17 cells accumulate at the inflammatory sites, such as the airways of allergic asthmatic patients.We investigated the activation of interleukin (IL)-17A on the primary human basophils/KU812 basophilic cells and primary human bronchial epithelial cells/BEAS-2B bronchial epithelial cells. Cytokines, chemokines, adhesion molecules and intracellular signalling molecules were assayed by ELISA or flow cytometry.Co-culture of bronchial epithelial cells and basophils could significantly induce the release of IL-6, an epithelial inflammatory cytokine, and CCL2, a chemokine for basophils, esosinophils and monocytes. Such induction was synergistically enhanced by IL-17A, and direct interaction between these two cells was necessary for IL-17A-induced IL-6 and CCL2 release. Surface expression of intercellular adhesion molecule-1 on bronchial epithelial cells was also upregulated upon their interaction. The interaction of basophils and bronchial epithelial cells under IL-17A stimulation was differentially regulated by extracellular signal-regulated kinase, c-Jun N-terminal protein kinase, p38 mitogen-activated protein kinase and nuclear factor-kB pathways.These findings suggest a novel immunopathological role of Th17 cells and basophils in allergic asthma through the activation of granulocyte-mediated inflammation initiated by the direct interaction between basophils and bronchial epithelial cells.
“…Npr3 (natriuretic peptide receptor-3) has previously been shown to be rapidly down-regulated after birth and is proposed to maintain the fetal lung in a fluid-filled state (32). Pld1 is a phosphatidylcholine-specific phospholipase expressed in the lung (33,34) that may be involved in surfactant metabolism.…”
Section: Discussionmentioning
confidence: 99%
“…In dataset L1, the time points can be represented as the vector (E14, E17, E19, P7, P14, P28), which is correlated with (0, 3,5,12,19,33). The time-to-birth profile is Abs((0, 3, 5, 12, 19, 33) -5.5) 5 (5.5, 2.5, 0.5, 6.5, 13.5, 27.5).…”
Section: Time/stage Of Lung Development and Time-to-birth Profiles Fomentioning
“…HBEpCs-Previous studies have demonstrated stimulation of mitogenic signaling pathways for S1P, LPA, and growth factors in human airway smooth muscle and epithelial cells (1,21,34,35). To examine ERK activation further, HBEpCs were challenged with 1 M LPA or 20 ng/ml PDGF-BB, and phosphorylation of ERK was analyzed by Western blotting with phospho-specific antibodies against threonine/ tyrosine residues.…”
Section: Lpa-induced Erk1/2 Activation Is Sensitive To Ag 1296 and Ptmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.